The Texas Cancer Center is a clinical research site located in Dallas, Texas, United States 75237.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
The Texas Cancer Center has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Lymphoma, T-Cell, Peripheral, Prostate Cancer, Metastatic Colorectal Cancer.
Sponsors: Eisai Inc., Novacea, US Oncology Research.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Texas Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Texas Cancer Center has 6 clinical trials on record, with 1 currently active. Their work covers Lymphoma, T-Cell, Peripheral, Prostate Cancer, Metastatic Colorectal Cancer.
Yes — The Texas Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.